XNZE
CVT
Market cap24mUSD
Nov 13, Last price
0.60NZD
Name
Comvita Ltd
Chart & Performance
P/E
—
P/S
0.23
EPS
—
Div Yield, %
1.67%
Shrs. gr., 5y
6.76%
Rev. gr., 5y
-0.29%
Revenues
192m
-4.11%
Net income
-105m
L+35.37%
CFO
34m
+540.09%
Dividend
Apr 03, 20240.0117647 NZD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Comvita Limited, along with its associated entities, specializes in the global production and distribution of natural health products. The company boasts a significant international presence, operating across diverse markets in Australasia, Asia (including China), North America, Europe, the Middle East, and Africa. Its extensive product portfolio features flagship items such as Manuka honey, propolis, and olive leaf extract. Additionally, it offers a wide array of medihoney, skincare, gourmet honey, elixirs, lozenges, and cider vinegar formulations, as well as dedicated solutions for oral and children's health. Comvita's range is meticulously designed to address diverse wellness needs, including supporting digestive health, soothing eczema-prone skin, boosting energy levels, promoting cardiovascular well-being, and fortifying immune support. The company also provides essential solutions for summer and travel requirements. Beyond product development, Comvita maintains a vertically integrated operational model, encompassing the ownership and management of apiaries (beekeeping operations), property assets, and valuable intellectual property. Established in 1974, Comvita Limited is headquartered in Te Puke, New Zealand.
Valuation
Title NZD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||